Trial Profile
In Vitro and in Vivo Studies of the Relative Mitochondrial Toxicity of Tenofovir Alafenamide (TAF) vs. Tenofovir Disoproxil Fumarate (TDF)
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 11 May 2022
Price :
$35
*
At a glance
- Drugs Tenofovir alafenamide (Primary) ; Tenofovir disoproxil fumarate (Primary) ; Antiretrovirals; Cobicistat/elvitegravir/emtricitabine/tenofovir alafenamide; Elvitegravir/emtricitabine/tenofovir disoproxil fumarate/cobicistat
- Indications HIV infections
- Focus Adverse reactions
- Acronyms UCLACAREMITO
- 12 Jan 2022 Status changed from recruiting to completed.
- 27 Apr 2021 Planned number of patients changed from 35 to 26.
- 27 Apr 2021 Status changed from active, no longer recruiting to recruiting.